Literature DB >> 34357477

Pilot Randomized Trial of an Expressive Writing Intervention to Reduce Sexual HIV-Transmission Risk and Substance Use Among Emerging Adult Gay and Bisexual Men.

Brooke E Wells1,2, Steven Samrock3, Mark Pawson4, Tyrel J Starks3,5.   

Abstract

This pilot randomized controlled trial evaluated the feasibility, acceptability, and preliminary efficacy of expressive writing to reduce HIV-related sexual risk taking and symptoms of drug dependence among emerging adult gay and bisexual men (EAGBM) through linguistic mechanisms involving use of words associated with cognitive processing (e.g., think, cause), positive emotion (e.g., love, nice), and negative emotion (e.g., hurt, shame). Between 2014 and 2015, EAGBM (n = 78; aged 18-29) completed a baseline survey and were randomized to complete three 15-min expressive writing or equivalent control-group writing sessions and follow-up assessments 2 months post-baseline. EAGBM in the expressive writing condition utilized significantly more positive emotion, negative emotion, and cognitive processing words. Path model results indicated the intervention condition resulted in significant reductions in symptoms of drug dependence and frequency of condomless anal sex (CAS) through paths mediated by positive emotion words, and significant increases in CAS through a path mediated by negative emotion words.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Drug use; Expressive writing; Gay and bisexual men; HIV prevention

Mesh:

Year:  2021        PMID: 34357477      PMCID: PMC8816814          DOI: 10.1007/s10461-021-03413-7

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  53 in total

1.  Emerging adulthood. A theory of development from the late teens through the twenties.

Authors:  J J Arnett
Journal:  Am Psychol       Date:  2000-05

Review 2.  Psychological aspects of natural language. use: our words, our selves.

Authors:  James W Pennebaker; Matthias R Mehl; Kate G Niederhoffer
Journal:  Annu Rev Psychol       Date:  2002-06-10       Impact factor: 24.137

3.  Ensuring Positiveness of the Scaled Difference Chi-square Test Statistic.

Authors:  Albert Satorra; Peter M Bentler
Journal:  Psychometrika       Date:  2010-06       Impact factor: 2.500

4.  Variations in the spacing of expressive writing sessions.

Authors:  Cindy K Chung; James W Pennebaker
Journal:  Br J Health Psychol       Date:  2008-02

Review 5.  Addressing sexual health behaviour during emerging adulthood: a critical review of the literature.

Authors:  Kamila A Alexander; Loretta S Jemmott; Anne M Teitelman; Patricia D'Antonio
Journal:  J Clin Nurs       Date:  2014-07-03       Impact factor: 3.036

6.  Predicting emotional health indicators from linguistic evidence of psychological distancing.

Authors:  Anoushka D Shahane; Bryan T Denny
Journal:  Stress Health       Date:  2019-01-30       Impact factor: 3.519

7.  The reliability of the CIDI-SAM: a comprehensive substance abuse interview.

Authors:  L B Cottler; L N Robins; J E Helzer
Journal:  Br J Addict       Date:  1989-07

8.  Substance use among lesbian, gay, and bisexual clients entering substance abuse treatment: Comparisons to heterosexual clients.

Authors:  Annesa Flentje; Nicholas C Heck; James L Sorensen
Journal:  J Consult Clin Psychol       Date:  2015-01-26

9.  Expressive Writing in Psychological Science.

Authors:  James W Pennebaker
Journal:  Perspect Psychol Sci       Date:  2017-10-09

10.  Gay-Specific and General Stressors Predict Gay Men's Psychological Functioning Over Time.

Authors:  Antonio Petruzzella; Brian A Feinstein; Joanne Davila; Justin A Lavner
Journal:  Arch Sex Behav       Date:  2020-03-07
View more
  1 in total

Review 1.  Behavioral and social interventions to promote optimal HIV prevention and care continua outcomes in the United States.

Authors:  Kristi E Gamarel; Wesley M King; Don Operario
Journal:  Curr Opin HIV AIDS       Date:  2022-03-01       Impact factor: 4.061

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.